Early biomarker for pancreatic cancer identified

( University of California - San Diego ) Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.

New York judge with cancer makes case for marijuana

NEW YORK (Reuters) - A cancer-stricken judge in New York has become an unlikely voice in support of legalizing the use of medical marijuana with the admission that he smokes pot to ease the side-effects of his treatments. Brooklyn Supreme Court Justice Gustin Reichbach, who is being treated for pancreatic cancer, wrote in a New York Times article on Thursday that he had been using marijuana ...

BSD Medical Reports Hyperthermia Clinical Study on Pancreatic Cancer Highlighted at Society of Thermal Medicine ...

BSD Medical Corporation , a leading provider of medical systems that utilize heat therapy to treat cancer, reported today that an important Phase III clinical study, hyperthermia in combination with chemotherapy for the treatment of pancreatic cancer patients, was the subject of a press release issued by The Society of Thermal Medicine .

Pancreatic cancer research topic of Campbell meeting

The Silicon Valley affiliate of the Pancreatic Cancer Action Network will hold a meeting on May 22 at the Campbell Library to discuss volunteer opportunities.

CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer

CytRx Corporation , a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas who have progressed after receiving two prior therapies.